- SEK35.85bn
- SEK77.20bn
- SEK7.14bn
- 60
- 37
- 46
- 42
Annual income statement for Pandox AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,115 | 3,273 | 5,654 | 6,849 | 7,136 |
| Cost of Revenue | |||||
| Gross Profit | 1,552 | 1,727 | 3,104 | 3,587 | 3,855 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,671 | 1,703 | 2,703 | 3,459 | 3,479 |
| Operating Profit | 1,444 | 1,570 | 2,951 | 3,390 | 3,657 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1,542 | 886 | 5,351 | -497 | 2,359 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1,408 | 609 | 4,204 | -580 | 1,706 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -1,399 | 610 | 4,217 | -585 | 1,689 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1,399 | 610 | 4,217 | -585 | 1,689 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7.83 | 3.32 | 22.9 | -3.18 | 9.03 |
| Dividends per Share |